Stelis's small-scale cGMP manufacturing facility is designed to support smallscale commercial and cGMP clinical trial material generation
Apollo Hospitals Chennai is the first healthcare institution in South India to use this protected TAVI / TAVR technology.
The innovative software module is designed to meet growing scientific demand from researchers and drug developers
The three-year collaboration will focus on the development of new tools for computational chemistry modelling as well as new molecular representations to advance the next generation of molecular machine learning
The new program includes upstream and downstream process development and large-scale GMP production.
Becomes the first airline globally to develop and launch sustainable, temperature-controlled containers for the transportation of pharmaceuticals
Gilman will be responsible for all business development and portfolio strategy efforts globally.
First and only FDA-approved device of its kind demonstrates consistently high rates of target limb salvage and freedom from clinically-driven target lesion revascularization
Acceptance based on results from the phase 3 KEYNOTE-091 trial
Group 4 Medulloblastoma is a rare disease that mostly affects pediatric patients, in which aberrant SRC signaling was identified as a hallmark of the disease
Subscribe To Our Newsletter & Stay Updated
